The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko

Episode Highlights0:15 Intro1:10 Introducing the Lung Health Cohort Research Study3:49 The enrollment strategy7:10 Seeking “the cholesterol of lung disease”11:50 The role of industry support14:09 Imaging strategies for long-term lung assessment17:59 Recruitment challenges23:05 Final thoughts26:20 OutroFor our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study. Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset. Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast